This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Suzhou Smartnuclide Biopharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Haijing Du - Innovator in Biomedicine
Introduction
Haijing Du is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biomedicine, particularly through his innovative work on PD-L1 binding polypeptides. His research focuses on the detection and diagnosis of PD-L1 related diseases, including various forms of cancer.
Latest Patents
Haijing Du holds a patent for a PD-L1-binding polypeptide and its applications. This invention is crucial in the medical field as it aids in identifying and diagnosing diseases associated with PD-L1, which is a significant biomarker in cancer research. The patent showcases his expertise and commitment to advancing biomedical science.
Career Highlights
Du is currently affiliated with Suzhou Smartnuclide Biopharmaceutical Co., Ltd., where he continues to push the boundaries of biopharmaceutical research. His work has garnered attention for its potential impact on cancer treatment and diagnostics.
Collaborations
Some of his notable coworkers include Yanling Yang and Hao Qi, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Haijing Du's innovative work in biomedicine exemplifies the importance of research in developing new diagnostic tools for cancer. His contributions are paving the way for advancements in the understanding and treatment of PD-L1 related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile